Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 296

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Long-term Persistence of Zoster Vaccine Efficacy

Open access
Morrison, Vicki A., Johnson, Gary R., Schmader, Kenneth E., Levin, Myron J., Zhang, Jane H., Looney, David J., Betts, Robert, Gelb, Larry, Guatelli, John C., Harbecke, Ruth, Pachucki, Connie, Keay, Susan, Menzies, Barbara, Griffin, Marie R., Kauffman, Carol A., Marques, Adriana, Toney, John, Boardman, Kathy, Su, Shu-Chih, Li, Xiaoming, Chan, Ivan S. F., Parrino, Janie, Annunziato, Paula, Oxman, Michael N., for the Shingles Prevention Study Group, Davis, LE., Kauffman, CA, Keay, SK, Straus, SE, Marques, AR, Soto, NE, Brunell, P, Gnann, JW, Serrao, R, Cotton, DJ, Goodman, RP, Arbeit, RD, Pachucki, CT, Levin, MJ, Schmader, KE, Keitel, WA, Greenberg, RN, Morrison, VA, Wright, PF, Griffin, MR, Simberkoff, MS, Yeh, SS, Lobo, Z, Holodniy, M, Loutit, J, Betts, RF, Gelb, LD, Crawford, GE, Guatelli, J, Brooks, PA, Looney, DJ, Neuzil, KM, Toney, JF, Kauffman, CA, Keay, SK, Marques, AR, Pachucki, CT, Levin, MJ, Schmader, KE, Morrison, VA, Wright, PF, Griffin, MR, Betts, RF, Gelb, LD, Guatelli, JC, Looney, DJ, Neuzil, KM, Menzies, B, Toney, JF·2015·Clinical Infectious Diseases

Abstract

BACKGROUND: The Shingles Prevention Study (SPS) demonstrated zoster vaccine efficacy through 4 years postvaccination. A Short-Term Persistence Substudy (STPS) demonstrated persistence of vaccine efficacy for at least 5 years. A Long-Term Persistence Substudy (LTPS) was undertaken to further assess vaccine efficacy in SPS vaccine recipients followed for up to 11 years postvaccination. Study outcomes were assessed for the entire LTPS period and for each year from 7 to 11 years postvaccination. METHODS: Surveillance, case determination, and follow-up were comparable to those in SPS and STPS. Because SPS placebo recipients were offered zoster vaccine before the LTPS began, there were no unvaccinated controls. Instead, SPS and STPS placebo results were used to model reference placebo groups. RESULTS: The LTPS enrolled 6867 SPS vaccine recipients. Compared to SPS, estimated vaccine efficacy in LTPS decreased from 61.1% to 37.3% for the herpes zoster (HZ) burden of illness (BOI), from 66.5% to 35.4% for incidence of postherpetic neuralgia, and from 51.3% to 21.1% for incidence of HZ, and declined for all 3 outcome measures from 7 through 11 years postvaccination. Vaccine efficacy for the HZ BOI was significantly greater than zero through year 10 postvaccination, whereas vaccine efficacy for incidence of HZ was significantly greater than zero only through year 8. CONCLUSIONS: Estimates of vaccine efficacy decreased over time in the LTPS population compared with modeled control estimates. Statistically significant vaccine efficacy for HZ BOI persisted into year 10 postvaccination, whereas statistically significant vaccine efficacy for incidence of HZ persisted only through year 8.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/ciu918

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 296

Metadata

Authors
Morrison, V. A., Johnson, G. R., Schmader, K. E., Levin, M. J., Zhang, J. H., Looney, D. J., Betts, R., Gelb, L., Guatelli, J. C., Harbecke, R., Pachucki, C., Keay, S., Menzies, B., Griffin, M. R., Kauffman, C. A., Marques, A., Toney, J., Boardman, K., Su, S.-C., Li, X., Chan, I. S. F., Parrino, J., Annunziato, P., Oxman, M. N., for the Shingles Prevention Study Group, Davis, L., Kauffman, C., Keay, S., Straus, S., Marques, A., Soto, N., Brunell, P., Gnann, J., Serrao, R., Cotton, D., Goodman, R., Arbeit, R., Pachucki, C., Levin, M., Schmader, K., Keitel, W., Greenberg, R., Morrison, V., Wright, P., Griffin, M., Simberkoff, M., Yeh, S., Lobo, Z., Holodniy, M., Loutit, J., Betts, R., Gelb, L., Crawford, G., Guatelli, J., Brooks, P., Looney, D., Neuzil, K., Toney, J., Kauffman, C., Keay, S., Marques, A., Pachucki, C., Levin, M., Schmader, K., Morrison, V., Wright, P., Griffin, M., Betts, R., Gelb, L., Guatelli, J., Looney, D., Neuzil, K., Menzies, B., & Toney, J.
Venue
Clinical Infectious Diseases
Published
2014-11-20
Volume
60
Issue
6
Pages
900-909
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2125575192
Cited by
296
References
20
FWCI
23.14
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term Persistence of Zoster Vaccine Efficacy. https://app.cochat.ai/papers/10.1093/cid/ciu918
The paper
Morrison, V. A., Johnson, G. R., Schmader, K. E., Levin, M. J., Zhang, J. H., Looney, D. J., Betts, R., Gelb, L., Guatelli, J. C., Harbecke, R., Pachucki, C., Keay, S., Menzies, B., Griffin, M. R., Kauffman, C. A., Marques, A., Toney, J., Boardman, K., Su, S.-C., . . . Toney, J. (2015). Long-term Persistence of Zoster Vaccine Efficacy. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciu918

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.